A “game-changer” jab to treat opioid dependence could ease pressure on health care services, outperforming other standard treatments, a new report involving University of Hertfordshire academics suggests. But the injection, known as Buvidal, should be offered as part of a wider, person-centered treatment system, integrated with psychological support and meaningful social activities, rather than positioned as a standalone solution, authors of the report recommend.
This article was originally published on MedicalXpress.com
